Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-08 4:30 pm Purchase | 13G | THIRD HARMONIC BIO INC THRD | Novartis Institutes for BioMedical Research Inc. | 2,642,762 6.5% | 2,642,762 (New Position) | View |
| 2022-10-31 4:00 pm Unchanged | 13G | AYALA PHARMACEUTICALS INC AYLA | Novartis Institutes for BioMedical Research Inc. | 698,777 4.7% | 0 (Unchanged) | View |
| 2022-08-31 4:05 pm Unchanged | 13G | PLIANT THERAPEUTICS INC PLRX | Novartis Institutes for BioMedical Research Inc. | 2,153,526 4.4% | 0 (Unchanged) | View |
| 2021-02-08 5:24 pm Unchanged | 13G | SURFACE ONCOLOGY INC SURF | Novartis Institutes for BioMedical Research Inc. | 3,948,482 9.71% | 0 (Unchanged) | View |
| 2021-02-05 5:17 pm Purchase | 13G | AYALA PHARMACEUTICALS INC AYLA | Novartis Institutes for BioMedical Research Inc. | 698,777 5.5% | 698,777 (New Position) | View |
| 2021-01-22 4:59 pm Sale | 13D | INTELLIA THERAPEUTICS INC NTLA | Novartis Institutes for BioMedical Research Inc. | 2,176,148 3.7% | -2,176,147 (-50.00%) | View |
| 2020-08-20 4:30 pm Unchanged | 13D | INTELLIA THERAPEUTICS INC NTLA | Novartis Institutes for BioMedical Research Inc. | 4,352,295 7.4% | 0 (Unchanged) | View |
| 2020-06-15 4:40 pm Purchase | 13G | PLIANT THERAPEUTICS INC PLRX | Novartis Institutes for BioMedical Research Inc. | 2,153,526 6.1% | 2,153,526 (New Position) | View |
| 2020-03-30 2:54 pm Purchase | 13D | INTELLIA THERAPEUTICS INC NTLA | Novartis Institutes for BioMedical Research Inc. | 4,352,295 8.6% | 75,222 (+1.76%) | View |
| 2020-03-10 12:20 pm Unchanged | 13G | HOMOLOGY MEDICINES INC FIXX | Novartis Institutes for BioMedical Research Inc. | 1,979,226 4.5% | 0 (Unchanged) | View |